The Effect of Fetal Liver-Derived Cell Suspension Allotransplantation on Patients with Diabetes: First Year of Follow-up

Stem cell-based therapies have recently opened up new horizons for treatment of various types of diseases including diabetes mellitus. However, long-term efficacy and safety of these novel modalities still remain a serious question. Hereby, we aim to report the one-year follow-up results in the diab...

Full description

Bibliographic Details
Main Authors: Maryam Ghodsi, Ramin Heshmat, Mahsa Amoli, Abbas-Ali Keshtkar, Babak Arjmand, Hamidreza Aghayan, Parviz Hosseini, Ali Mohammad Sharifi, Bagher Larijani
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2012-08-01
Series:Acta Medica Iranica
Subjects:
Online Access:http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/22152.pdf&manuscript_id=22152
id doaj-d2483f94f6684e80bfd64a3117ccb42b
record_format Article
spelling doaj-d2483f94f6684e80bfd64a3117ccb42b2020-11-25T02:00:32ZengTehran University of Medical SciencesActa Medica Iranica0044-60250173-59692012-08-01508541546The Effect of Fetal Liver-Derived Cell Suspension Allotransplantation on Patients with Diabetes: First Year of Follow-upMaryam GhodsiRamin HeshmatMahsa AmoliAbbas-Ali KeshtkarBabak ArjmandHamidreza AghayanParviz HosseiniAli Mohammad SharifiBagher LarijaniStem cell-based therapies have recently opened up new horizons for treatment of various types of diseases including diabetes mellitus. However, long-term efficacy and safety of these novel modalities still remain a serious question. Hereby, we aim to report the one-year follow-up results in the diabetic patients who underwent fetal liver-derived hematopoietic stem cell allotransplantation. Fifty six patients with type one (n=30) and type two (n=26) diabetes, aged 10-58 years old (32.8 ± 16.3) were divided into the intervention and placebo group. The patients in the intervention group underwent fetal liver-derived hematopoietic stem cell transplantation while the patients in the placebo group received 5 ml of normal saline both via an intravenous route. The patients were visited at regular intervals to evaluate the efficacy of transplantation in glycemic control as well as possible complications. In the 6th month of the follow-up, there was a significant decrease in HbA1c levels in all groups without any rise in the fasting c-peptide. However, none of the precipitants transiently or continuously became insulin free in the first year after transplantation. It can be concluded that, in this study, fetal liver-derived hematopoietic stem cell transplantation had no significant effects on glycemic control. The heterogeneity of our patients might account for the negative results. Hence, longer follow-up results will be reported in the near future.http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/22152.pdf&manuscript_id=22152Diabetes mellitusFetal hematopoietic stem cellsCell therapy
collection DOAJ
language English
format Article
sources DOAJ
author Maryam Ghodsi
Ramin Heshmat
Mahsa Amoli
Abbas-Ali Keshtkar
Babak Arjmand
Hamidreza Aghayan
Parviz Hosseini
Ali Mohammad Sharifi
Bagher Larijani
spellingShingle Maryam Ghodsi
Ramin Heshmat
Mahsa Amoli
Abbas-Ali Keshtkar
Babak Arjmand
Hamidreza Aghayan
Parviz Hosseini
Ali Mohammad Sharifi
Bagher Larijani
The Effect of Fetal Liver-Derived Cell Suspension Allotransplantation on Patients with Diabetes: First Year of Follow-up
Acta Medica Iranica
Diabetes mellitus
Fetal hematopoietic stem cells
Cell therapy
author_facet Maryam Ghodsi
Ramin Heshmat
Mahsa Amoli
Abbas-Ali Keshtkar
Babak Arjmand
Hamidreza Aghayan
Parviz Hosseini
Ali Mohammad Sharifi
Bagher Larijani
author_sort Maryam Ghodsi
title The Effect of Fetal Liver-Derived Cell Suspension Allotransplantation on Patients with Diabetes: First Year of Follow-up
title_short The Effect of Fetal Liver-Derived Cell Suspension Allotransplantation on Patients with Diabetes: First Year of Follow-up
title_full The Effect of Fetal Liver-Derived Cell Suspension Allotransplantation on Patients with Diabetes: First Year of Follow-up
title_fullStr The Effect of Fetal Liver-Derived Cell Suspension Allotransplantation on Patients with Diabetes: First Year of Follow-up
title_full_unstemmed The Effect of Fetal Liver-Derived Cell Suspension Allotransplantation on Patients with Diabetes: First Year of Follow-up
title_sort effect of fetal liver-derived cell suspension allotransplantation on patients with diabetes: first year of follow-up
publisher Tehran University of Medical Sciences
series Acta Medica Iranica
issn 0044-6025
0173-5969
publishDate 2012-08-01
description Stem cell-based therapies have recently opened up new horizons for treatment of various types of diseases including diabetes mellitus. However, long-term efficacy and safety of these novel modalities still remain a serious question. Hereby, we aim to report the one-year follow-up results in the diabetic patients who underwent fetal liver-derived hematopoietic stem cell allotransplantation. Fifty six patients with type one (n=30) and type two (n=26) diabetes, aged 10-58 years old (32.8 ± 16.3) were divided into the intervention and placebo group. The patients in the intervention group underwent fetal liver-derived hematopoietic stem cell transplantation while the patients in the placebo group received 5 ml of normal saline both via an intravenous route. The patients were visited at regular intervals to evaluate the efficacy of transplantation in glycemic control as well as possible complications. In the 6th month of the follow-up, there was a significant decrease in HbA1c levels in all groups without any rise in the fasting c-peptide. However, none of the precipitants transiently or continuously became insulin free in the first year after transplantation. It can be concluded that, in this study, fetal liver-derived hematopoietic stem cell transplantation had no significant effects on glycemic control. The heterogeneity of our patients might account for the negative results. Hence, longer follow-up results will be reported in the near future.
topic Diabetes mellitus
Fetal hematopoietic stem cells
Cell therapy
url http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/22152.pdf&manuscript_id=22152
work_keys_str_mv AT maryamghodsi theeffectoffetalliverderivedcellsuspensionallotransplantationonpatientswithdiabetesfirstyearoffollowup
AT raminheshmat theeffectoffetalliverderivedcellsuspensionallotransplantationonpatientswithdiabetesfirstyearoffollowup
AT mahsaamoli theeffectoffetalliverderivedcellsuspensionallotransplantationonpatientswithdiabetesfirstyearoffollowup
AT abbasalikeshtkar theeffectoffetalliverderivedcellsuspensionallotransplantationonpatientswithdiabetesfirstyearoffollowup
AT babakarjmand theeffectoffetalliverderivedcellsuspensionallotransplantationonpatientswithdiabetesfirstyearoffollowup
AT hamidrezaaghayan theeffectoffetalliverderivedcellsuspensionallotransplantationonpatientswithdiabetesfirstyearoffollowup
AT parvizhosseini theeffectoffetalliverderivedcellsuspensionallotransplantationonpatientswithdiabetesfirstyearoffollowup
AT alimohammadsharifi theeffectoffetalliverderivedcellsuspensionallotransplantationonpatientswithdiabetesfirstyearoffollowup
AT bagherlarijani theeffectoffetalliverderivedcellsuspensionallotransplantationonpatientswithdiabetesfirstyearoffollowup
AT maryamghodsi effectoffetalliverderivedcellsuspensionallotransplantationonpatientswithdiabetesfirstyearoffollowup
AT raminheshmat effectoffetalliverderivedcellsuspensionallotransplantationonpatientswithdiabetesfirstyearoffollowup
AT mahsaamoli effectoffetalliverderivedcellsuspensionallotransplantationonpatientswithdiabetesfirstyearoffollowup
AT abbasalikeshtkar effectoffetalliverderivedcellsuspensionallotransplantationonpatientswithdiabetesfirstyearoffollowup
AT babakarjmand effectoffetalliverderivedcellsuspensionallotransplantationonpatientswithdiabetesfirstyearoffollowup
AT hamidrezaaghayan effectoffetalliverderivedcellsuspensionallotransplantationonpatientswithdiabetesfirstyearoffollowup
AT parvizhosseini effectoffetalliverderivedcellsuspensionallotransplantationonpatientswithdiabetesfirstyearoffollowup
AT alimohammadsharifi effectoffetalliverderivedcellsuspensionallotransplantationonpatientswithdiabetesfirstyearoffollowup
AT bagherlarijani effectoffetalliverderivedcellsuspensionallotransplantationonpatientswithdiabetesfirstyearoffollowup
_version_ 1724959934225842176